Showing all 4 results

  • Lamotrigine Tablets

    Free

    Product Composition & Available Strengths

    Because Lamotrigine demands highly delicate, low-dose introductory titration to ensure patient dermatological safety, we manufacture the full compendial strength matrix.

    Active Ingredient MonographAvailable StrengthsFormulation Matrix Delivery SystemPrimary Clinical Application
    Lamotrigine USP / BP / IP25 mgOral Solid Uncoated / Dispersible TabletDermatological Intro Titration: Mandatory low-dose baseline format utilized exclusively for the critical initial 2-week dose-escalation phase.
    Lamotrigine USP / BP / IP50 mgOral Solid Uncoated / Dispersible TabletIntermediate Step-Up Dosing: Step-up strength calibrated for weeks 3 and 4 of therapy to safely approach steady-state plasma metrics.
    Lamotrigine USP / BP / IP100 mgOral Solid Compressed TabletStandard Maintenance Block: First-line international standard strength for adult maintenance monotherapy in epilepsy and bipolar stabilization.
    Lamotrigine USP / BP / IP200 mgOral High-Potency Solid TabletMaximal Saturation Maintenance: High-strength configuration calibrated for advanced refractory partial seizures and combination therapies.
  • Oxcarbazepine Tablet

    Free

    Product Composition & Available Strengths

    We manufacture Oxcarbazepine in the full, internationally standardized range of strengths to allow for the precise, progressive dose titration mandatory in anti-epileptic therapy.

    Active IngredientAvailable StrengthsPrimary Clinical Target
    Oxcarbazepine IP / BP / USP150 mgPediatric & Initial Titration: For low-dose introductory phases to assess patient tolerance.
    Oxcarbazepine IP / BP / USP300 mgStandard Maintenance: The foundational daily maintenance dose for adolescent and adult stabilization.
    Oxcarbazepine IP / BP / USP600 mgHigh-Potency Control: For refractory focal seizures or high-threshold therapeutic stabilization.
  • Phenobarbital Tablets

    Free

    Phenobarbitone Tablets IP
    Each Uncoated tablet contains :
    Phenobarbitone IP 30 mg
    Excipients q.s

    Phenobarbitone Tablets IP 60 mg
    Phenobarbital Tablets IP 60 mg
    Each Uncoated tablet contains :
    Phenobarbitone IP 60 mg
    Phenobarbital
    Excipients q.s

    Phenobarbital Tablets BP
    Each Uncoated tablet contains :
    Phenobarbital BP 30 mg

    Phenobarbital Tablets BP 60 mg
    Each Uncoated tablet contains :
    Phenobarbital BP 60 mg Excipients q.s

    PHENOBARBITAL TABLETS BP 90 MG                                                                  Each Uncoated tablet contains :                                                                                Phenobarbital BP 90 mg
    Excioients 0 QS

    Phenobarbital Tablets BP 100 mg
    Each Uncoated tablet contains :
    Phenobarbital BP 100 mg                                                                                          Excipients -QS

    Usage: – To control seizures

    Category: – Anti Hypertensive / Cardiac Drugs

    Therapeutic category: – Hypertensive

  • Zonisamide Capsules

    Free

    Zonisamide capsules are antiepileptic medications used as adjunctive therapy for adults and adolescents with partial-onset seizures. They are chemically classified as sulfonamides.